Literature DB >> 19232893

Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease.

Craig D Blinderman1, Peter Homel, J Andrew Billings, Sharon Tennstedt, Russell K Portenoy.   

Abstract

Although chronic obstructive pulmonary disease (COPD) is a highly prevalent and disabling illness, few empirical studies have evaluated the impact of the disease on symptom distress, functional status, and quality of life. These outcomes were explored in a prospective survey of 100 patients with advanced COPD. Patients were recruited from two academic centers. The mean forced expiratory volume in 1 second (FEV1) was 24.4% (standard deviation=3.9). Validated instruments were used to assess symptom distress (Memorial Symptom Assessment Scale [MSAS]), mental health (Mental Health Inventory [MHI]-5), functional status (Sickness Impact Profile [SIP]), quality of life (Multidimensional Index of Life Quality [MILQ]), spirituality (Functional Assessment of Chronic Illness Therapy [FACIT] Spirituality Scale), and comorbid conditions (Charlson Comorbidity Index). The most prevalent symptoms were dyspnea (94%), fatigue (71%), xerostomia (60%), coughing (56%), and anxiety (51%). Other symptoms with high prevalence were drowsiness (47%), irritability (42%), feeling nervous (40%), and wheezing (40%). Significant pain was reported in about one-third of patients. Patients reported relatively high levels of overall functional impairment (SIP median=24.0) and modest impairment in overall quality of life (MILQ median=52). Overall, psychological well-being was relatively unimpaired (median=24.5), and the comfort derived from faith was intact (FACIT median=2.5). Impairment in quality of life was strongly associated with symptom distress (MSAS-GDI; r=-0.74, P<0.001), functional impairment (SIP total; r=-0.59, P<0.001), female sex (r=-0.26, P=0.01), and poor psychological well-being (MHI-5; r=0.68, P<0.001). In multivariate analyses, poor quality of life was strongly correlated with higher total symptom distress, sickness-related dysfunction, and lower levels of psychological well-being (R(2)=0.66). In addition, two specific psychological symptoms-worrying and feeling irritable-were independently predictive of poor quality of life. Patients with advanced COPD have multiple distressing symptoms and a high prevalence of disturbances in mood, functional status, and quality of life. A focus on ameliorating prevalent physical symptoms and psychological distress may lead to an improvement in the overall quality of life in this patient population.

Entities:  

Mesh:

Year:  2009        PMID: 19232893     DOI: 10.1016/j.jpainsymman.2008.07.006

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  71 in total

1.  Measurement of Irritability in Cancer Patients.

Authors:  Amy Y Zhang; Stephen J Ganocy
Journal:  Nurs Res       Date:  2020 Mar/Apr       Impact factor: 2.381

2.  Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease.

Authors:  Signe Berit Bentsen; Christine Miaskowski; Tone Rustøen
Journal:  Qual Life Res       Date:  2013-09-03       Impact factor: 4.147

3.  For better or for worse: a longitudinal study on dyadic coping and quality of life among couples with a partner suffering from COPD.

Authors:  Isabelle Vaske; Maximiliane Florentine Thöne; Kerstin Kühl; Daniel Christian Keil; Wolfgang Schürmann; Winfried Rief; Nikola Maria Stenzel
Journal:  J Behav Med       Date:  2015-07-09

4.  Cognition and physical disability in predicting health-related quality of life in multiple sclerosis.

Authors:  Marietta Hoogs; Sukhmit Kaur; Audrey Smerbeck; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Int J MS Care       Date:  2011

5.  Effect of symptoms on physical performance in COPD.

Authors:  Jungeun Lee; Huong Q Nguyen; Monica E Jarrett; Pamela H Mitchell; Kenneth C Pike; Vincent S Fan
Journal:  Heart Lung       Date:  2018-02-01       Impact factor: 2.210

6.  Outpatient palliative care for chronic obstructive pulmonary disease: a case series.

Authors:  Clara Schroedl; Susan Yount; Eytan Szmuilowicz; Sharon R Rosenberg; Ravi Kalhan
Journal:  J Palliat Med       Date:  2014-06-16       Impact factor: 2.947

7.  Nutrition impact symptoms and body composition in patients with COPD.

Authors:  J Nordén; A M Grönberg; I Bosaeus; H Bertéus Forslund; L Hulthén; E Rothenberg; J Karlsson; O Wallengren; F Slinde
Journal:  Eur J Clin Nutr       Date:  2014-05-07       Impact factor: 4.016

8.  Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial.

Authors:  Julie Lasselin; Michael T Treadway; Tamara E Lacourt; Anne Soop; Mats J Olsson; Bianka Karshikoff; Sofie Paues-Göranson; John Axelsson; Robert Dantzer; Mats Lekander
Journal:  Neuropsychopharmacology       Date:  2016-09-13       Impact factor: 7.853

9.  Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Janet L Larson
Journal:  J Clin Nurs       Date:  2014-01-27       Impact factor: 3.036

10.  Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis.

Authors:  Donna Goodridge; Josh Lawson; Graeme Rocker; Darcy Marciniuk; Donna Rennie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.